Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1287617 Target Snapshot

UDP-glucuronosyltransferase 1A1 · SINGLE PROTEIN · Homo sapiens

244Compounds
133Assays
7Approved Drugs
64.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P22309. Use UniProt P22309 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P22309 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats UDP-glucuronosyltransferase 1A1 as ChEMBL target CHEMBL1287617, mapped to UniProt P22309. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
UDP-glucuronosyltransferase 1A1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1287617
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P22309
UDP-glucuronosyltransferase 1A1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether UDP-glucuronosyltransferase 1A1 is the right protein anchor across sources, using UniProt P22309 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelUDP-glucuronosyltransferase 1A1
UniProt AccessionP22309
Component TypeProtein
Sequence Length533 aa

UDP-glucuronosyltransferase 1A1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as UDP-glucuronosyltransferase 1A1, mapped to UniProt P22309. Sequence length is 533 aa.

Mapped IDP22309
Review nameUDP-glucuronosyltransferase 1A1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

7
Approved
5
Phase II
Assay Mix

Activity Type Distribution

IC5056.0
KI8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1163 6.52 IC50 300.0 Approved
CHEMBL139702 6.01 IC50 970.0 Preclinical
CHEMBL4227228 6.0 IC50 1000.0 Preclinical
CHEMBL5179012 6.0 IC50 1000.0 Preclinical
CHEMBL4573938 5.96 IC50 1100.0 Preclinical
CHEMBL5437552 5.89 IC50 1300.0 Preclinical
CHEMBL4209316 5.85 IC50 1400.0 Preclinical
CHEMBL4794465 5.85 IC50 1400.0 Preclinical
CHEMBL5182534 5.82 IC50 1500.0 Preclinical
CHEMBL3222137 5.81 Ki 1540.0 Preclinical
Distribution

pChEMBL Value Distribution

11
5.0
11
5.5
5
6.0
2
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ATAZANAVIR
CHEMBL1163
Approved 2003
Assay Landscape

Assay Landscape

133
Total Assays
30
Tested Compounds
2
Assay Types
ADME — 122 assays, 30 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 61 10 5.4
cell-based format 26 18 5.0
assay format 24 0
microsome format 11 2 5.9
Binding — 11 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 10 8 5.5
microsome format 1 2 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine